SRPT vs RXRX

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 09, 2026

SRPT

29.6
AI Score
VS
RXRX Wins

RXRX

42.1
AI Score

Investment Advisor Scores

SRPT

30score
Recommendation
SELL

RXRX

42score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric SRPT RXRX Winner
Revenue 1.13B 14.14M SRPT
Net Income 326.07M -248.51M SRPT
Net Margin 28.8% -1757.1% SRPT
Operating Income 371.72M -263.47M SRPT
ROE 21.3% -27.2% SRPT
ROA 10.2% -20.5% SRPT
Total Assets 3.19B 1.21B SRPT
Cash 571.15M 545.68M SRPT
Current Ratio 4.42 5.03 RXRX
Free Cash Flow -8.25M -187.35M SRPT

Relative Price Performance (Last 90 Days)

SRPT 1M: +11.3% · 3M: +36.3% RXRX 1M: -2.7% · 3M: +1.6%

Current Technical Phase

SRPT

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (9.1% over 20 days), RSI 53

RSI (14): 52.9 · Price: $20.45

RXRX

Distribution
Trim / tighten stop

Price near a flattening SMA50 (slope 0.1%) with fading momentum, RSI 46

RSI (14): 45.6 · Price: $3.20

Fundamentals Snapshot

Metric SRPT RXRX
Market Cap
Forward P/E 8.0 -3.6
Trailing P/E
Revenue (TTM)
Revenue Growth -0.3% -0.6%
Gross Margin 0.2% -7.2%
Operating Margin 0.1% -17.6%
EPS -1.57 -0.98
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, RXRX is currently the stronger investment candidate, winning 1 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.